Clinica Baviera - Public Comps and Valuation Multiples

Clinica Baviera Overview

About Clinica Baviera

Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.

Founded

1992

HQ

Employees

882

Website

clinicabaviera.com

Sectors

Hospitals & Clinics
Medical Imaging & Diagnostics
Laboratory Services
HealthTech

Financials

LTM Revenue $337M

LTM EBITDA $91.4M

EV

$738M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Clinica Baviera Financials

As of September 2025, Clinica Baviera reported last 12-month revenue of $337M and EBITDA of $91.4M.

In the same period, Clinica Baviera achieved $44.4M in LTM net income.

See Clinica Baviera valuation multiples based on analyst estimates

Clinica Baviera P&L

In the most recent fiscal year, Clinica Baviera reported revenue of $304M and EBITDA of $90.3M.

Clinica Baviera expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Clinica Baviera valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$337M	XXX	$304M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$268M	XXX	XXX	XXX
Gross Margin	n/a	XXX	88%	XXX	XXX	XXX
EBITDA	$91.4M	XXX	$90.3M	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBIT	$64.7M	XXX	$64.4M	XXX	XXX	XXX
EBIT Margin	19%	XXX	21%	XXX	XXX	XXX
Net Profit	$44.4M	XXX	$46.5M	XXX	XXX	XXX
Net Margin	13%	XXX	15%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Clinica Baviera including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $337M. EBITDA for the last twelve months was $91.4M. In the most recent fiscal year, Clinica Baviera achieved $304M in revenue and $90.3M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$337M	Analyst estimates available to subscribers	$304M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$268M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	88.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$91.4M	Analyst estimates available to subscribers	$90.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	27.1% EBITDA margin	Analyst estimates available to subscribers	29.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$64.7M	Analyst estimates available to subscribers	$64.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	19.2% EBIT margin	Analyst estimates available to subscribers	21.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$44.4M	Analyst estimates available to subscribers	$46.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	13.2% net profit margin	Analyst estimates available to subscribers	15.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Clinica Baviera

This financial data table provides comprehensive performance metrics for Clinica Baviera, a company based in Spain. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Clinica Baviera generated $337M in revenue over the last twelve months.
The company achieved $91.4M in EBITDA over the last twelve months.
Net income over the last twelve months reached $44.4M.

Fiscal Year Performance

In the most recent fiscal year, Clinica Baviera reported $304M in total revenue.
Fiscal year EBITDA was $90.3M.
The company maintained a gross profit margin of 88.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 29.7%.
Net profit margin reached 15.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Clinica Baviera. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Clinica Baviera Stock Performance

Clinica Baviera has current market cap of EUR 669M (or $774M), and EV of EUR 638M (or $738M).

Market Cap Evolution

Clinica Baviera Stock Data

As of October 20, 2025, Clinica Baviera's stock price is EUR 42 (or $48).

See Clinica Baviera trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$738M	$774M	XXX	XXX	XXX	XXX	$2.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Clinica Baviera Valuation Multiples

Clinica Baviera's trades at 2.4x EV/Revenue multiple, and 8.2x EV/EBITDA.

See valuation multiples for Clinica Baviera and 15K+ public comps

Clinica Baviera Financial Valuation Multiples

As of October 20, 2025, Clinica Baviera has market cap of $774M and EV of $738M.

Equity research analysts estimate Clinica Baviera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Clinica Baviera has a P/E ratio of 17.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$774M	XXX	$774M	XXX	XXX	XXX
EV (current)	$738M	XXX	$738M	XXX	XXX	XXX
EV/Revenue	2.2x	XXX	2.4x	XXX	XXX	XXX
EV/EBITDA	8.1x	XXX	8.2x	XXX	XXX	XXX
EV/EBIT	11.4x	XXX	11.5x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	17.4x	XXX	16.6x	XXX	XXX	XXX
EV/FCF	40.4x	XXX	17.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Clinica Baviera Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Clinica Baviera Margins & Growth Rates

Clinica Baviera's last 12 month revenue growth is 11%

Clinica Baviera's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Clinica Baviera's rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clinica Baviera's rule of X is 54% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Clinica Baviera and other 15K+ public comps

Clinica Baviera Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	11%	XXX	12%	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	15%	XXX	9%	XXX	XXX	XXX
Rule of 40	41%	XXX	40%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	54%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	5%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	67%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial